Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

Premature aging increases the risk of immune problems and autoimmune diseases.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Extracellular vesicles can worsen Alzheimer's but also offer potential for diagnosis and treatment.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Skin problems are common in kidney disease, with dry skin and itching in patients not on dialysis or on hemodialysis, and infections most common in transplant recipients.

BST2 protein and certain T cells increase in early alopecia areata.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

A mutation in the KRT71 gene causes a hair disorder by disrupting hair follicle structure and texture.

PEODDN is a rare skin disorder with limited treatment options, best treated with laser therapy.

Patients with the same vitamin D receptor mutation showed different symptoms due to other factors.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Keratoacanthoma changes as it grows, showing different hair follicle characteristics at each stage.

A man with a rare disease experienced late hair whitening and loss, but hair color returned, suggesting a good outlook.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Non-coding RNAs may be key in diagnosing and treating rare skin disorders.

A 36-year-old man had unusual skin lesions on his face without hair loss.

Sensory neuron and Merkel cell changes in the skin happen independently during normal skin maintenance.

Pancreatic cancer can alter gut and skin bacteria, possibly causing skin issues.

DM and AA may share a common cause.

Human skin has less GDNF and its receptor with age.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Skin organoids can model tuberculosis infection and help test treatments.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Proper diet management is crucial for preventing severe symptoms in phenylketonuria.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.